mutations bckd-kinase lead potentially treatable form autism epilepsy
autism spectrum disorders genetically heterogeneous constellation syndromes characterized impairments reciprocal social interaction available somatic treatments limited efficacy identified inactivating mutations gene bckdk branched chain ketoacid dehydrogenase kinase consanguineous families autism epilepsy intellectual disability encoded protein responsible phosphorylation-mediated inactivation e1 alpha subunit branched-chain ketoacid dehydrogenase bckdh patients homozygous bckdk mutations display reductions bckdk messenger rna protein e1 alpha phosphorylation plasma branched-chain amino acids bckdk knockout mice show abnormal brain amino acid profiles neurobehavioral deficits respond dietary supplementation thus autism presenting intellectual disability epilepsy caused bckdk mutations represents potentially treatable syndrome
